AI-Accelerated Market Entry for a Global CPG Leader
Using AI to compress months of market research into weeks, identifying where a global CPG leader could move fast on emerging wellness opportunities created by the rise of GLP-1 medications.
Client
Global Fortune 100 CPG company
ROLE
Director, AI Strategy & Innovation
Challenge
A legacy CPG company with decades of brand equity was navigating a rapidly shifting consumer health landscape. The rise of GLP-1 medications was reshaping purchasing behavior, creating threats to existing product lines and significant new market opportunities.
Solution
Used AI-native research and synthesis tools to compress months of market analysis into weeks. Applied large language models to synthesize consumer sentiment, competitive dynamics, and clinical trend data across the GLP-1 landscape, surfacing non-obvious opportunities for the client to explore.
Result
Delivered a prioritized set of market entry opportunities, a premiumization strategy for a legacy global brand, and a pipeline of new concepts - in a fraction of the time traditional strategy work would have required.
